Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors
Clinical trial NCT02723864 · COMPLETED
Trial details
- NCT number
- NCT02723864
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-09
- Primary completion
- 2020-12-15
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.